Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma
Open Access
- 17 November 2003
- Vol. 98 (11) , 2351-2361
- https://doi.org/10.1002/cncr.11804
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Prostate cancer epidemiologyThe Lancet, 2003
- Early prostate cancer: clinical decision-makingThe Lancet, 2003
- Locally advanced prostate cancerCurrent Treatment Options in Oncology, 2001
- RTOG protocol 92-02: A phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trialsThe Lancet, 2000
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997
- Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patientsThe Lancet, 1995
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995
- Endocrine-Induced Regression of CancersScience, 1967